Correction to: Nature Communications https://doi.org/10.1038/s41467-020-16225-5, published online 15 May 2020.
The original version of this Article contained an error in the Acknowledgments, which incorrectly read “The research leading to these results has received funding from the New York Stem Cell Foundation (to M.P.), the European Research Council (ERC Grant Agreement no. 30971, to M.P.), the Swedish Research Council [grant agreements 521-2012-5624 (to M.P.), 2016-02506 (to T.P.) and 70862601/Bagadilico)], Swedish Parkinson Foundation (Parkinsonfonden, to M.P.), Swedish Brain Foundation (Hjärnfonden, to M.P.), the Strategic Research Area at Lund University Multipark (Multidisciplinary research in Parkinson’s disease), StratRegen grant Karolinska Institutet (to T.P.); Knut and Alice Wallenberg Foundation (to T.P.), Söderbergs Stiftelse (to T.P.) and Svenska Sällskapet för Medicinsk Forskning (to K.T.). M.P. is a New York Stem Cell Foundation—Robertson Investigator.’
The correct version states ‘ERC Grant Agreement no. 771427, to M.P.’ in place of ‘ERC Grant Agreement no. 30971, to M.P.’
This has been corrected in both the PDF and HTML versions of the Article.
About this article
Cite this article
Tiklová, K., Nolbrant, S., Fiorenzano, A. et al. Author Correction: Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson’s disease. Nat Commun 11, 3630 (2020). https://doi.org/10.1038/s41467-020-17421-z
Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson’s Disease. A Systematic Review
Frontiers in Aging Neuroscience (2021)